共 45 条
[1]
Fischbach W(2009)S3-guideline „helicobacter pylori and gastroduodenal ulcer disease“ of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001 Zeitschrift fur Gastroenterologie 47 1230-63
[2]
Malfertheiner P(2015)Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits Gastroenterology 148 719-31
[3]
Hoffmann JC(2013)Eradication of gastric cancer is now both possible and practical Seminars in cancer biology 23 492-501
[4]
Bolten W(2013)Primary antimicrobial resistance of Helicobacter pylori in Belgium Acta clinica Belgica 68 183-7
[5]
Bornschein J(2015)Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study World journal of gastroenterology: WJG 21 2786-92
[6]
Gotze O(2000)A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection Alimentary pharmacology & therapeutics 14 603-9
[7]
Graham DY(2007)Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication Annals of internal medicine 147 553-62
[8]
Shiotani A(2012)undefined (EHSG): Management of Helicobacter pylori infection the Maastricht IV/ Florence Consensus Report Gut 61 646e664-undefined
[9]
Cen P(undefined)undefined undefined undefined undefined-undefined
[10]
Graham DY(undefined)undefined undefined undefined undefined-undefined